Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [18F]NaF PET/CT study-Reference-Cited by-同舟云学术

Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [18F]NaF PET/CT study

Published:2019-07 Issue: Volume:124 Page:1-6
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Botman Esmée,Raijmakers Pieter G.H.M.,Yaqub Maqsood,Teunissen Bernd,Netelenbos Coen,Lubbers Wouter,Schwarte Lothar A.,Micha Dimitra^ORCID,Bravenboer Nathalie,Schoenmaker Ton^ORCID,de Vries Teun J.,Pals Gerard,Smit Jan Maerten,Koolwijk Pieter,Trotter Dinko González,Lammertsma Adriaan A.,Eekhoff E. Marelise W.^ORCID

Funder

Regeneron Pharmaceuticals Inc.

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients;Cohen;J. Bone Joint Surg. Am.,1993

2. Fibrodysplasia ossificans progressiva. A survey of forty-two cases;Rogers;J. Bone Joint Surg. Am.,1979

3. Fibrodysplasia ossificans progressiva;Kaplan;Best Pract. Res. Clin. Rheumatol.,2008

4. The natural history of flare-ups in Fibrodysplasia Ossificans Progressiva (FOP): a comprehensive global assessment;Pignolo;J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.,2016

5. The radiological spectrum of fibrodysplasia ossificans progressiva;Cremin;Clin. Radiol.,1982

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of heterotopic ossification maturity using SPECT/CT and PET/CT in preclinical model;Nuclear Medicine and Biology;2024-09

2. Performance of simplified methods for quantification of [18F]NaF uptake in fibrodysplasia ossificans progressiva;Frontiers in Nuclear Medicine;2024-07-22

3. Fibrodysplasia ossificans progressiva (clinical observation with a brief review of the literature);N.N. Priorov Journal of Traumatology and Orthopedics;2024-07-04

4. 18F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults;JBMR Plus;2024-01-04

5. Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial;Nature Medicine;2023-09-28